These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 2660901

  • 1. Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia.
    Federico M, Chisesi T, Lauria F, Bernasconi C, Capnist G, Castoldi G, Damasio E, Pagnucco G, Frassoldati A, Resegotti L.
    Br J Haematol; 1989 May; 72(1):54-6. PubMed ID: 2660901
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M, Frassoldati A, Lamparelli T, Foà R, Brugiatelli M, Annino L, Baldini L, Capnist G, Chisesi T, di Celle PF.
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [Abstract] [Full Text] [Related]

  • 3. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE, Frassoldati A.
    Leuk Lymphoma; 1994 Oct; 14 Suppl 1():95-8. PubMed ID: 7820061
    [Abstract] [Full Text] [Related]

  • 4. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
    Capnist G, Federico M, Chisesi T, Resegotti L, Pagnucco G, Castoldi GL, Lamparelli T, Frassoldati A, Guarnaccia C, Leoni P.
    Leuk Res; 1991 Oct; 15(6):419-26. PubMed ID: 1861528
    [Abstract] [Full Text] [Related]

  • 5. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
    Damasio EE, Federico M, Frassoldati A, Lamparelli T, Annino L, Bernasconi C, Chisesi T, Foá R, Lauria F, Pagnucco G.
    Eur J Haematol Suppl; 1990 Oct; 52():29-31. PubMed ID: 2279542
    [Abstract] [Full Text] [Related]

  • 6. Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
    Federico M, Frassoldati A, Pagnucco G, Lamparelli T, Capnist G, Chisesi T, Guarnaccia C, Lauria F, Resegotti L, Rossi G.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():179-81. PubMed ID: 2653499
    [No Abstract] [Full Text] [Related]

  • 7. Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).
    Capnist G, Federico M, Chisesi T, Resegotti L, Lamparelli T, Fabris P, Rossi G, Invernizzi R, Guarnaccia C, Leoni P.
    Leuk Lymphoma; 1994 Aug; 14(5-6):457-64. PubMed ID: 7812205
    [Abstract] [Full Text] [Related]

  • 8. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE, Bernasconi C, Castoldi GL, Chisesi T, Federico M, Lamparelli T, Lauria F, Pagnucco G, Resegoti L, Rossi E.
    Leukemia; 1987 Apr; 1(4):331-3. PubMed ID: 3669757
    [Abstract] [Full Text] [Related]

  • 9. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H, Braide I, Lisse I, Röckert LL, Swolin B, Carneskog J, Hagberg H, Hippe E, Jensen MK, Lundin P.
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
    Lauria F, Foà R, Raspadori D, Zinzani PL, Buzzi M, Fierro MT, Bonferroni M, Fanin R, Gallizia C, Michieli MG.
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
    [Abstract] [Full Text] [Related]

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Feb; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 12. Interferon is effective in hairy-cell leukaemia.
    Worman CP, Catovsky D, Bevan PC, Camba L, Joyner M, Green PJ, Williams HJ, Bottomley JM, Gordon-Smith EC, Cawley JC.
    Br J Haematol; 1985 Aug; 60(4):759-63. PubMed ID: 3875366
    [Abstract] [Full Text] [Related]

  • 13. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia.
    Frassoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco G, Dini E, Resegotti L, Damasio EE, Silingardi V.
    Leuk Lymphoma; 1994 Apr; 13(3-4):307-16. PubMed ID: 7519510
    [Abstract] [Full Text] [Related]

  • 14. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM, Dodge R, Mick R, Budman D, Hutchison R, Horning SJ, Schiffer CA.
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [Abstract] [Full Text] [Related]

  • 15. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [Abstract] [Full Text] [Related]

  • 16. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB, Wolska-Smolen T, Blicharski J, Zduńczyk A, Sasiadek U, Pituch-Noworolska A.
    Cancer Detect Prev; 1988 Nov; 12(1-6):511-22. PubMed ID: 3180143
    [Abstract] [Full Text] [Related]

  • 17. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H, Zwingers T, Boedewadt S, Bross K, Dörken B, Gamm H, Ho AD, Parwaresch RM, Schmitz N, Papendick U.
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [Abstract] [Full Text] [Related]

  • 18. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M, Rolović Z, Vuković S, Elezović I, Tomić D.
    Srp Arh Celok Lek; 1990 Feb; 118(7-8):277-84. PubMed ID: 2097776
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR, Hesdorffer CS, Dansey RD, Lewis D.
    S Afr Med J; 1987 Nov 21; 72(10):661-2. PubMed ID: 3686262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.